Self-Assembling Benzothiazole-Based Gelators: A Mechanistic Understanding of in Vitro Bioactivation and Gelation.

Low molecular weight gelators (LMWGs) of chemotherapeutic drugs represent a valid alternative to the existing polymer-based formulations used for targeted delivery of anticancer drugs. Herein we report the design and development of novel self-assembling gelators of the antitumor benzothiazole 5F 203 (1). Two different types of derivatives of 1 were synthesized, formed by an amide (2) and a carbamate (3a-3d) linker, respectively, which showed potent in vitro antitumor activity against MCF-7 mammary and IGROV-1 ovarian carcinoma cells. In contrast, MRC-5 fibroblasts were inherently resistant to the above derivatives (GI50 > 10 μM), thus revealing stark selectivity against the malignant cell lines over the nontransformed fibroblasts. Western blots assays demonstrated induction of CYP1A1 by 1 and its derivatives only in sensitive malignant cells (MCF-7), corroborating conservation of a CYP1A1-mediated mechanism of action. The ability to form stable gels under relatively high strains was supported by rheological tests; in addition, their inner morphology was characterized as possessing a crossed-linked nanostructure, with the formation of thick aggregates with variable widths between 1100 and 400 nm and lengths from 8 to 32 μm. Finally, in vitro dissolution studies proved the ability of hydrogel 2 to release 48% of 2 within 80 h, therefore demonstrating its ability to act as a platform for localized delivery.

[1]  D. Adams,et al.  Correction: Fmoc-diphenylalanine hydrogels: understanding the variability in reported mechanical properties. , 2012, Soft matter.

[2]  Jie Zhou,et al.  Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials , 2015, Chemical reviews.

[3]  P. Dastidar,et al.  A supramolecular topical gel derived from a non-steroidal anti-inflammatory drug, fenoprofen, is capable of treating skin inflammation in mice. , 2015, Organic & biomolecular chemistry.

[4]  Charlotte A. E. Hauser,et al.  Short to ultrashort peptide hydrogels for biomedical uses , 2014 .

[5]  Shiping Yang,et al.  (-)-Menthol based thixotropic hydrogel and its application as a universal antibacterial carrier. , 2014, Soft matter.

[6]  Ran Tian,et al.  The development of low-molecular weight hydrogels for applications in cancer therapy. , 2014, Nanoscale.

[7]  T. Bradshaw,et al.  Insights into low molecular mass organic gelators: a focus on drug delivery and tissue engineering applications. , 2014, Soft matter.

[8]  J. Karp,et al.  Prodrugs as self-assembled hydrogels: a new paradigm for biomaterials. , 2013, Current opinion in biotechnology.

[9]  T. Bradshaw,et al.  Biomarkers of sensitivity to potent and selective antitumor 2‐(4‐amino‐3‐methylphenyl)‐5‐fluorobenzothiazole (5F203) in ovarian cancer , 2013, Journal of cellular biochemistry.

[10]  Faming Gao,et al.  Nanostructures and self-assembly of organogels via benzimidazole/benzothiazole imide derivatives with different alkyl substituent chains , 2013 .

[11]  Faming Gao,et al.  Self-assembly and soft material preparation of binary organogels via aminobenzimidazole/benzothiazole and acids with different alkyl substituent chains , 2013 .

[12]  G. Liang,et al.  Folic acid as a versatile motif to construct molecular hydrogelators through conjugations with hydrophobic therapeutic agents , 2012 .

[13]  Huaimin Wang,et al.  Molecular hydrogelators consist of Taxol and short peptides/amino acids , 2012 .

[14]  F. Guengerich,et al.  Bioactivation of fluorinated 2-aryl-benzothiazole antitumor molecules by human cytochrome P450s 1A1 and 2W1 and deactivation by cytochrome P450 2S1. , 2012, Chemical research in toxicology.

[15]  Kai Hung Tiong,et al.  CYP2S1 and CYP2W1 Mediate 2-(3,4-Dimethoxyphenyl)-5-Fluorobenzothiazole (GW-610, NSC 721648) Sensitivity in Breast and Colorectal Cancer Cells , 2011, Molecular Cancer Therapeutics.

[16]  T. Bradshaw.  Phortress: the smart antitumour agent which induces its own metabolism , 2010 .

[17]  Bing Xu,et al.  Enzyme-instructed molecular self-assembly confers nanofibers and a supramolecular hydrogel of taxol derivative. , 2009, Journal of the American Chemical Society.

[18]  M. Stevens,et al.  2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole is a ligand and shows species-specific partial agonism of the aryl hydrocarbon receptor. , 2009, Toxicology and applied pharmacology.

[19]  Paul Sanderson,et al.  A new method for maintaining homogeneity during liquid–hydrogel transitions using low molecular weight hydrogelators , 2009 .

[20]  J. Karp,et al.  Self-assembled prodrugs: an enzymatically triggered drug-delivery platform. , 2009, Biomaterials.

[21]  M. Stevens,et al.  Preclinical Toxicokinetic Evaluation of Phortress [2-(4-Amino-3-Methylphenyl)-5-Fluorobenzothiazole Lysylamide Dihydrochloride] in Two Rodent Species , 2008, Pharmacology.

[22]  Jing Liu,et al.  New dicholesteryl-based gelators: gelling ability and selective gelation of organic solvents from their mixtures with water at room temperature , 2008 .

[23]  Tycho Heimbach,et al.  Prodrugs: design and clinical applications , 2008, Nature Reviews Drug Discovery.

[24]  J. M. Clancy,et al.  Prodrugs for Amines , 2008, Molecules.

[25]  A. Westwell,et al.  The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. , 2004, Current medicinal chemistry.

[26]  E. Sausville,et al.  Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3-methylphenyl)benzothiazoles. , 2002, Molecular cancer therapeutics.

[27]  M. Stevens,et al.  Antitumor benzothiazoles. 16. Synthesis and pharmaceutical properties of antitumor 2-(4-aminophenyl)benzothiazole amino acid prodrugs. , 2002, Journal of medicinal chemistry.

[28]  M. Stevens,et al.  Antitumor benzothiazoles. 14. Synthesis and in vitro biological properties of fluorinated 2-(4-aminophenyl)benzothiazoles. , 2001, Journal of medicinal chemistry.

[29]  H. Schwam,et al.  (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes. , 1988, Journal of medicinal chemistry.

[30]  A. Repta,et al.  N-(acyloxyalkoxycarbonyl) derivatives as potential prodrugs of amines. I: Kinetics and mechanism of degradation in aqueous solutions , 1987 .